Canadians need to know more about the drugs we take
Why is Health Canada only letting doctors and the public know part of the story about the safety and effectiveness of pharmaceutical drugs? Inadequate information can be dangerous and misleading.
Roojin Habibi is an MSc candidate in McMaster University's Global Health program, and a Research Fellow at the Pharmaceutical Policy Research Collaboration (PPRC). Joel Lexchin is an advisor with EvidenceNetwork.ca and a professor in the School of Health Policy and Management at York University, an emergency physician at the University Health Network and an associate professor in the Department of Family and Community Medicine at the University of Toronto.